Literature DB >> 20631091

Fusion-active glycoprotein G mediates the cytotoxicity of vesicular stomatitis virus M mutants lacking host shut-off activity.

Markus Hoffmann1, Yuan-Ju Wu, Markus Gerber, Marianne Berger-Rentsch, Bernd Heimrich, Martin Schwemmle, Gert Zimmer.   

Abstract

The cytopathogenicity of vesicular stomatitis virus (VSV) has been attributed mainly to the host shut-off activity of the viral matrix (M) protein, which inhibits both nuclear transcription and nucleocytoplasmic RNA transport, thereby effectively suppressing the synthesis of type I interferon (IFN). The M protein from persistently VSV-infected cells was shown to harbour characteristic amino acid substitutions (M51R, V221F and S226R) implicated in IFN induction. This study demonstrates that infection of human fibroblasts with recombinant VSV containing the M51R substitution resulted in IFN induction, whereas neither the V221F nor the S226R substitution effected an IFN-inducing phenotype. Only when V221F was combined with S226R were the host shut-off activity of the M protein abolished and IFN induced, independently of M51R. The M33A substitution, previously implicated in VSV cytotoxicity, did not affect host shut-off activity. M-mutant VSV containing all four amino acid substitutions retained cytotoxic properties in both Vero cells and IFN-competent primary fibroblasts. Infected-cell death was associated with the formation of giant polynucleated cells, suggesting that the fusion activity of the VSV G protein was involved. Accordingly, M-mutant VSV expressing a fusion-defective G protein or with a deletion of the G gene showed significantly reduced cytotoxic properties and caused long-lasting infections in Vero cells and mouse hippocampal slice cultures. In contrast, a G-deleted VSV expressing wild-type M protein remained cytotoxic. These findings indicate that the host shut-off activity of the M protein dominates VSV cytotoxicty, whilst the fusion-active G protein is mainly responsible for the cytotoxicity remaining with M-mutant VSV.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20631091     DOI: 10.1099/vir.0.023978-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  42 in total

1.  Mutations in the glycoprotein of vesicular stomatitis virus affect cytopathogenicity: potential for oncolytic virotherapy.

Authors:  Valérie Janelle; Frédérick Brassard; Pascal Lapierre; Alain Lamarre; Laurent Poliquin
Journal:  J Virol       Date:  2011-05-11       Impact factor: 5.103

Review 2.  Vesicular stomatitis virus as a flexible platform for oncolytic virotherapy against cancer.

Authors:  Eric Hastie; Valery Z Grdzelishvili
Journal:  J Gen Virol       Date:  2012-10-10       Impact factor: 3.891

3.  The immune response to a vesicular stomatitis virus vaccine vector is independent of particulate antigen secretion and protein turnover rate.

Authors:  Melissa A Cobleigh; Clinton Bradfield; Yuanjie Liu; Anand Mehta; Michael D Robek
Journal:  J Virol       Date:  2012-02-15       Impact factor: 5.103

4.  Quantitative Proteomics of Uukuniemi Virus-host Cell Interactions Reveals GBF1 as Proviral Host Factor for Phleboviruses.

Authors:  Zina M Uckeley; Rebecca Moeller; Lars I Kühn; Emma Nilsson; Claudia Robens; Lisa Lasswitz; Richard Lindqvist; Annasara Lenman; Vania Passos; Yannik Voss; Christian Sommerauer; Martin Kampmann; Christine Goffinet; Felix Meissner; Anna K Överby; Pierre-Yves Lozach; Gisa Gerold
Journal:  Mol Cell Proteomics       Date:  2019-09-30       Impact factor: 5.911

5.  Recombinant Modified Vaccinia Virus Ankara Generating Ebola Virus-Like Particles.

Authors:  Marc Schweneker; Andrea S Laimbacher; Gert Zimmer; Susanne Wagner; Elisabeth M Schraner; Michael Wolferstätter; Marieken Klingenberg; Ulrike Dirmeier; Robin Steigerwald; Henning Lauterbach; Hubertus Hochrein; Paul Chaplin; Mark Suter; Jürgen Hausmann
Journal:  J Virol       Date:  2017-05-12       Impact factor: 5.103

6.  Anterograde or retrograde transsynaptic labeling of CNS neurons with vesicular stomatitis virus vectors.

Authors:  Kevin T Beier; Arpiar Saunders; Ian A Oldenburg; Kazunari Miyamichi; Nazia Akhtar; Liqun Luo; Sean P J Whelan; Bernardo Sabatini; Constance L Cepko
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-08       Impact factor: 11.205

7.  Absence of a robust innate immune response in rat neurons facilitates persistent infection of Borna disease virus in neuronal tissue.

Authors:  Chia-Ching Lin; Yuan-Ju Wu; Bernd Heimrich; Martin Schwemmle
Journal:  Cell Mol Life Sci       Date:  2013-06-23       Impact factor: 9.261

Review 8.  Understanding and altering cell tropism of vesicular stomatitis virus.

Authors:  Eric Hastie; Marcela Cataldi; Ian Marriott; Valery Z Grdzelishvili
Journal:  Virus Res       Date:  2013-06-22       Impact factor: 3.303

9.  Pseudotyping vesicular stomatitis virus with lymphocytic choriomeningitis virus glycoproteins enhances infectivity for glioma cells and minimizes neurotropism.

Authors:  Alexander Muik; Inna Kneiske; Marina Werbizki; Doris Wilflingseder; Tsanan Giroglou; Oliver Ebert; Anna Kraft; Ursula Dietrich; Gert Zimmer; Stefan Momma; Dorothee von Laer
Journal:  J Virol       Date:  2011-03-30       Impact factor: 5.103

10.  Chicken cells sense influenza A virus infection through MDA5 and CARDIF signaling involving LGP2.

Authors:  Matthias Liniger; Artur Summerfield; Gert Zimmer; Kenneth C McCullough; Nicolas Ruggli
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.